Mineralys Therapeutics (MLYS) Amortizatization of Intangibles (2022 - 2026)

Mineralys Therapeutics has disclosed Amortizatization of Intangibles across 5 years of filings, most recently posting $4.6 million for Q1 2026.

• Amortizatization of Intangibles for Q1 2026 came in at $4.6 million, up 342.16% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.5 million (up 69.45% YoY), and the FY2025 annual result was $9.9 million, up 5.04% from the prior year.
• Amortizatization of Intangibles came in at $4.6 million for Q1 2026 at Mineralys Therapeutics, up from $4.2 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $4.6 million in Q1 2026 to a low of $239000.0 in Q3 2022.
• The 5-year median for Amortizatization of Intangibles is $2.1 million (2023), against an average of $2.1 million.
• Across the five-year window, Amortizatization of Intangibles surged 720.92% in 2023 and plunged 58.31% in 2025, its largest moves.
• Mineralys Therapeutics' Amortizatization of Intangibles stood at $410000.0 in 2022, then surged by 403.9% to $2.1 million in 2023, then tumbled by 35.29% to $1.3 million in 2024, then jumped by 214.73% to $4.2 million in 2025, then increased by 9.91% to $4.6 million in 2026.
• The last three Amortizatization of Intangibles figures came in at $4.6 million (Q1 2026), $4.2 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.